IP Library Granted Patent US 8,282,963
Granted Patent B2
US 8,282,963 · App. 12/682,782 · Granted Oct 9, 2012

Methods for extracting platelets and compositions obtained therefrom

Assignee: The Regents of the University of Colorado, a body corporate
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,282,963
App. No.
12/682,782
Granted
Oct 9, 2012
Kind
B2
Abstract

This invention provides methods for extracting platelets, compositions obtained therefore, and methods for using the same.

Claims (30)

1. A composition comprising a growth factor produced by a process comprising:

disrupting pelletized platelets in an extraction solution to produce an insoluble material portion and the extraction solution comprising a growth factor; and

removing insoluble materials and proteins having molecular weight of 2 kD or less from said extraction solution to produce a composition comprising a growth factor.

2. The composition of claim 1 , wherein said method for disrupting pelletized platelets comprises sonication, homogenization, nitrogen cavitation, a French pressure cell, or a combination thereof.

3. The composition of claim 1 , wherein said step of removing insoluble materials and proteins comprises:

(i) filtering said extraction solution using an ultrafiltration process to remove insoluble materials and proteins having molecular weight of 2 kD or less; or

(ii) removing insoluble materials from said extraction solution; and

(a) dialyzing said extraction solution against an acidic solution using a semipermeable membrane having 2 kD or less MWCO; or

(b) filtering said extraction solution using an ultrafiltration process to remove proteins having molecular weight of 2 kD or less.

4. The composition of claim 3 , wherein said step of dialyzing comprises using a semipermeable membrane having 8 kD or less MWCO.

5. The composition of claim 1 , wherein said process further comprises subjecting said extraction solution to an ultrafiltration process to remove any microorganisms that maybe present.

6. The composition of claim 5 , wherein said process further comprises lyophilizing said extraction solution to produce a solid composition comprising the growth factor.

7. The composition of claim 6 , wherein said process further comprises dissolving said solid composition in a solution to produce a fluid composition comprising the growth factor.

8. The composition of claim 1 , wherein said growth factor comprises VEGF, TGF-β 1 , TGF-β 2 , PDGF-BB, EGF, or a mixture thereof.

9. A wound healing composition comprising therapeutically effective amount of a composition of claim 1 and a pharmaceutically acceptable carrier.

10. The wound healing composition of claim 9 , wherein said pharmaceutically acceptable carrier comprises a bandage.

11. The wound healing composition of claim 9 , wherein the pharmaceutically acceptable carrier comprises a pharmaceutically acceptable polymer.

12. A process for producing a platelet extract having an angiogenic activity comprising:

disrupting pelletized platelets in an extraction solution to produce an insoluble material portion and the extraction solution comprising a growth factor; and

removing insoluble materials and proteins having molecular weight of 2 kD or less from the extraction solution to produce a platelet extract having an angiogenic activity.

13. The process of claim 12 , wherein said method for disrupting pelletized platelets comprises sonication, homogenization, nitrogen cavitation, a French pressure cell, or a combination thereof.

14. The process of claim 12 , wherein said step of removing insoluble materials and proteins comprises:

(i) filtering the extraction solution using an ultrafiltration process to remove insoluble materials and proteins having molecular weight of 2 kD or less; or

(ii) removing insoluble materials from the extraction solution; and

(a) dialyzing the extraction solution against an acidic solution using a semipermeable membrane having 2 kD or less MWCO; or

(b) filtering the extraction solution using an ultrafiltration process to remove proteins having molecular weight of 2 kD or less.

15. The process of claim 14 , wherein said step of dialyzing comprises using a semipermeable membrane having 8 kD or less MWCO.

16. The process of claim 12 further comprising subjecting the platelet extract to an ultrafiltration process to remove any microorganisms that maybe present.

17. The process of claim 16 further comprising lyophilizing the platelet extract to produce a solid platelet extract.

18. The process of claim 17 further comprising dissolving the solid platelet extract in a solution to produce a platelet extract solution.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2018
From: REGENTS OF THE UNIVERSITY OF COLORADO
To: ROEDERSHEIMER, MARK
Reel/Frame 047122/0753 →
CONFIRMATORY LICENSE Recorded Oct 26, 2011
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027129/0209 →
Continuity (2)
Provisional Application 60980159 · Oct 15, 2007
Related Publication 20100222253A1 · Sep 2, 2010